Effect of Blueberries on Immunity
Blueberry
Immune Benefits of Blueberry Consumption in Overweight Older Men and Postmenopausal Women: A Randomized Trial
1 other identifier
interventional
52
1 country
1
Brief Summary
This research study will test the effects of Blueberries on immune functions in overweight older men and postmenopausal women
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
September 10, 2022
CompletedStudy Start
First participant enrolled
October 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2023
CompletedFebruary 4, 2026
February 1, 2026
11 months
September 6, 2022
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
changes in lymphocyte populations
Immunophenotyping will be performed by flow cytometry to measure the number of T helper, T cytotoxic, Naïve and memory cells and B cells
baseline to 12 weeks
changes in cytokine production
PBMC cells will be separated from blood, activated and cultured using phytohemagglutinin (PHA). Inflammatory cytokine production will be measured in the resulting supernatant using ELISA
baseline to 12 weeks
changes in natural killer (NK) cell activity
The NK degranulation assay will be performed on blood samples. The test will be conducted using a modified flow cytometry method that measures the expression of CD107a
baseline to 12 weeks
changes in serum inflammatory cytokine concentration
Changes in the concentrations of the inflammatory cytokines will be performed on serum using enzyme-linked immunoassay (ELISA)
baseline to 12 weeks
changes in complete blood count (CBC)
changes in the complete blood count will be performed on whole blood with the use of an automated hematology analyzer at a certified clinical facility
baseline to 12 weeks
Study Arms (2)
Blueberry powder group
EXPERIMENTALParticipants in the blueberry powder group will receive freeze dried blueberries in form of a powder
Placebo powder group
PLACEBO COMPARATORParticipants in the placebo group will receive an isocaloric placebo powder.
Interventions
Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder
Participants in the placebo powder group will receive an isocaloric placebo powder
Eligibility Criteria
You may qualify if:
- Older men and post-menopausal women aged 50-70 year
- Have BMI of 25-32
- Able to commute to Loma Linda University
- Consuming a typical American Diet low in polyphenols
You may not qualify if:
- Intolerance or allergy to Blueberries
- Regular intake of Blueberries and other berried (\>2 ounces/week)
- Immune system insufficiency or disease
- Using immune boosting supplements
- Exposure to antibiotics and corticoids immediately prior to study
- Uncontrolled chronic diseases and relevant psychiatric illness, including major depression
- Flu vaccination and or Covid Vaccination less than 3 months ago from the start of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Loma Linda Universitylead
- U.S. Highbush Blueberry Councilcollaborator
Study Sites (1)
Loma Linda University School of Public Health
Loma Linda, California, 92350, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joan Sabate, DrPH
Loma Linda University
- PRINCIPAL INVESTIGATOR
Sujatha Rajaram, PhD
Loma Linda University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The investigator, participant, care provider, outcomes assessor will not be aware of which participant is in which arm
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2022
First Posted
September 10, 2022
Study Start
October 12, 2022
Primary Completion
September 12, 2023
Study Completion
September 12, 2023
Last Updated
February 4, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share